MRNA is trading at $50.52 (-5.15%) as broader market indices decline following hotter-than-expected PPI data and rising geopolitical tensions.
- The stock is tracking broader market sentiment with the Dow down 0.50% amid rising oil prices and Middle East instability.
- Recent inflation data from CPI and PPI reports have significantly dimmed hopes for near-term Federal Reserve rate cuts.
- No company-specific news has been reported for Moderna, indicating the sell-off is primarily driven by macroeconomic factors.